This validation cohort contained additional molecular features that were not available in our discovery cohort; however, we found no significant associations between the HPS and mismatch repair, CIMP or CIN status, nor mutations in TP53, KRAS and BRAF (online supplemental figure 4F). This evidence concerns the gene KRAS and cervical squamous intraepithelial neoplasia.